What is CaNCURE?

CaNCURE was created to provide Northeastern University undergrads with experiential training in cancer nanomedicine.  Over 50 trainees have already completed the program.
Our co-op students spend 6-months performing hands-on research in a NCI-funded research lab.   This research experience is supplemented with research and bio/nano innovation seminars, professional development activities, and opportunities to present research.
 Our alumni have successfully found new co-op and jobs in cancer research, scholarships to medical school, and scholarships to graduate school.  58% of alumni are currently performing cancer research.

66

Trainees

33

Mentors

22

Publications

108

Presentations


Hear from our Alumni:

“During my previous co-op, I worked with many patients who either had cancer or had side effects from radiation treatments 10-15 years later. Watching this process made me wonder about alternative treatment methods that would cause fewer harmful side-effects. As someone aiming to enter the field of medicine, participating in CaNCURE and exploring the possibilities behind nanomedicine allows me to see how cancer treatment is continuing to develop.”

Melissa Templeton, Health Sci., ’16


Trainee Spotlight


Daem Celestin

Cell and Molecular Biology, '21

The Nano-plasmonic Exosome (nPLEX) Assay for Pancreatic Ductal Adenocarcinoma Diagnosis and Prognosis

Vivian Zhang

Chemical Eng / Biochemistry, '21

Creating Animal Models of High-grade Serous Ovarian Cancer Cells

Rreze Grajcevci

Health Sciences, '21

Analyzing metastasis through targeted miRNA nanotherapy in aggressive breast cancer

Featured Trainee Publication


Upcoming Events

Recent Advances in the Knowledge Base of Nanotoxicology: Pulmonary Responses to Carbon Nanotubes

Tuesday, February 19, 2019

Vincent Castranova, PhD Department of Pharmaceutical Sciences, West Virginia University

119 Snell Libary -- NEU, 3:25 PM


Mentor Spotlight


Rebecca Carrier, Ph.D.

Associate Professor of Chemical Engineering,

Our lab seeks to design nanoemulsions to improve the delivery of hydrophobic chemo-therapeutic agents with minimal side effects. Students will work to gain a quantitative understanding of how properties of a given drug, lipid and surfactant, formulated in a specific way, can interact with the biological environment to facilitate drug release and absorption.


Zdravka Medarova, Ph.D.

Associate Professor in Radiology, MGH/MIT/HMS

The focus of my research has been the development and testing of multi-functional imaging/delivery vehicles for combined cancer imaging and therapy. More recently, our lab developed magnetic nanoparticles as delivery vehicles of miRNA-targeted therapy to breast tumors.


Trainee Spotlight


Daem Celestin

Cell and Molecular Biology, '21

The Nano-plasmonic Exosome (nPLEX) Assay for Pancreatic Ductal Adenocarcinoma Diagnosis and Prognosis

Vivian Zhang

Chemical Eng / Biochemistry, '21

Creating Animal Models of High-grade Serous Ovarian Cancer Cells

Rreze Grajcevci

Health Sciences, '21

Analyzing metastasis through targeted miRNA nanotherapy in aggressive breast cancer


 Get Involved

Interested in learning how nanomedicine is used to detect and treat cancer? Want to get involved in developing new nanotechnologies for the clinic? We are looking to match undergrads at Northeastern University with leading Boston researchers and clinicians for a six-month, hands-on research experience.  If you are thinking about a career in cancer science, engineering, or medicine, come get involved in the world’s first undergraduate program in cancer nanomedicine!  We have 9 upcoming openings for the January – June 2019 co-op period.  We will be accepting applications starting in September 2018 via NUcareers.

Going on in the lab right now...